Analysis: Many clinical trials are too small

Cancer drug studies and other clinical trials often have too few participants or are not designed well enough to yield robust results, according to a study of the database published in the Journal of the American Medical Association. Moreover, data included on the registry are often incomplete, missing even the trial's purpose in 7% of entries.

View Full Article in:

Analysis Finds Clinical Trials Often Small, of Poor Quality - HealthDay News · Drug and device trials vary in size, quality: study - Reuters

Published in Briefs: